These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 18157530

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of painful bone metastases in hormone-refractory prostate cancer with zoledronic acid and samarium-153-ethylenediaminetetramethylphosphonic acid combined.
    Lam MG, de Klerk JM, Zonnenberg BA.
    J Palliat Med; 2009 Jul; 12(7):649-51. PubMed ID: 19594354
    [Abstract] [Full Text] [Related]

  • 3. Is ¹⁵³Samarium-ethylene-diamine-tetramethyl-phosphonate (EDTMP) bone uptake influenced by bisphosphonates in patients with castration-resistant prostate cancer?
    Waldert M, Klatte T, Remzi M, Sinzinger H, Kratzik C.
    World J Urol; 2012 Apr; 30(2):233-7. PubMed ID: 21559805
    [Abstract] [Full Text] [Related]

  • 4. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
    Anderson PM, Wiseman GA, Dispenzieri A, Arndt CA, Hartmann LC, Smithson WA, Mullan BP, Bruland OS.
    J Clin Oncol; 2002 Jan 01; 20(1):189-96. PubMed ID: 11773169
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Samarium for osteoblastic bone metastases and osteosarcoma.
    Anderson P.
    Expert Opin Pharmacother; 2006 Aug 01; 7(11):1475-86. PubMed ID: 16859431
    [Abstract] [Full Text] [Related]

  • 7. Prospective evaluation of samarium-153-EDTMP radionuclide treatment for bone metastases in patients with hormone-refractory prostate cancer.
    Dolezal J, Vizda J, Odrazka K.
    Urol Int; 2007 Aug 01; 78(1):50-7. PubMed ID: 17192733
    [Abstract] [Full Text] [Related]

  • 8. Lack of effect of a bisphosphonate (pamidronate disodium) infusion on subsequent skeletal uptake of Sm-153 EDTMP.
    Marcus CS, Saeed S, Mlikotic A, Mishkin F, Pham HL, Javellana T, Diestelhorst S, Minami C.
    Clin Nucl Med; 2002 Jun 01; 27(6):427-30. PubMed ID: 12045435
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
    Brenner W, Kampen WU, Kampen AM, Henze E.
    J Nucl Med; 2001 Feb 01; 42(2):230-6. PubMed ID: 11216521
    [Abstract] [Full Text] [Related]

  • 12. Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial.
    Collins C, Eary JF, Donaldson G, Vernon C, Bush NE, Petersdorf S, Livingston RB, Gordon EE, Chapman CR, Appelbaum FR.
    J Nucl Med; 1993 Nov 01; 34(11):1839-44. PubMed ID: 8229221
    [Abstract] [Full Text] [Related]

  • 13. Samarium-153-EDTMP in bone metastases.
    Ahonen A, Joensuu H, Hiltunen J, Hannelin M, Heikkilä J, Jakobsson M, Jurvelin J, Kairemo K, Kumpulainen E, Kulmala J.
    J Nucl Biol Med (1991); 1994 Dec 01; 38(4 Suppl 1):123-7. PubMed ID: 7543288
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic, Dosimetry and Toxicity Study of ¹⁷⁷Lu-EDTMP in Patients: Phase 0/I study.
    Bal C, Arora G, Kumar P, Damle N, Das T, Chakraborty S, Banerjee S, Venkatesh M, Zaknun JJ, Pillai MR.
    Curr Radiopharm; 2016 Dec 01; 9(1):71-84. PubMed ID: 25771371
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer.
    Sartor O, Reid RH, Hoskin PJ, Quick DP, Ell PJ, Coleman RE, Kotler JA, Freeman LM, Olivier P, Quadramet 424Sm10/11 Study Group.
    Urology; 2004 May 01; 63(5):940-5. PubMed ID: 15134985
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.